Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
B Gao, L He, Y Bao, Y Chen, G Lu, Y Zhang, Y Xu… - Cell Research, 2023 - nature.com
Dear Editor, Since the emergence of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) in 2019, the virus has continued to evolve resulting in new waves of infection …
(SARS-CoV-2) in 2019, the virus has continued to evolve resulting in new waves of infection …
[引用][C] Omicron overpowers key COVID antibody treatments in early tests
M Kozlov - 2021 - sabinai-neji.com
Strained hospitals bracing for a COVID-19 surge caused by the quickly spreading Omicron
variant could face another grim possibility: preliminary experiments suggest that most of the …
variant could face another grim possibility: preliminary experiments suggest that most of the …
Real-world COVID-19 vaccine effectiveness against the Omicron BA. 2 variant in a SARS-CoV-2 infection-naive population
Abstract The SARS-CoV-2 Omicron variant has demonstrated enhanced transmissibility and
escape of vaccine-derived immunity. Although first-generation vaccines remain effective …
escape of vaccine-derived immunity. Although first-generation vaccines remain effective …
SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination
Omicron Neutralization and mRNA-1273 Boosters Neutralization of the omicron variant was
assessed in serum samples obtained from persons who had received an mRNA-1273 …
assessed in serum samples obtained from persons who had received an mRNA-1273 …
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
The emergence of the SARS-CoV-2 variant of concern Omicron (Pango lineage B. 1.1. 529),
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …
Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
L Wang, M Møhlenberg, P Wang, H Zhou - Cytokine & growth factor …, 2023 - Elsevier
Since its emergence at the end of 2019, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused the infection of more than 600 million people worldwide and has …
(SARS-CoV-2) has caused the infection of more than 600 million people worldwide and has …
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
The highly transmissible Omicron (B. 1.1. 529) variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) was first detected in late 2021. Initial Omicron waves were …
coronavirus 2 (SARS-CoV-2) was first detected in late 2021. Initial Omicron waves were …
Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants
Understanding the epidemic growth of the novel SARS-CoV-2 Omicron variant is critical for
public health. We compared the ten-day secondary attack rate (SAR) of the Omicron and …
public health. We compared the ten-day secondary attack rate (SAR) of the Omicron and …
[HTML][HTML] Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization
Vaccine effectiveness is lower and wanes faster against infection and symptomatic disease
caused by the omicron variant of SARS-CoV-2 than was observed with previous variants …
caused by the omicron variant of SARS-CoV-2 than was observed with previous variants …
Neutralization profile after recovery from SARS-CoV-2 omicron infection
A Rössler, L Knabl, D von Laer… - New England Journal of …, 2022 - Mass Medical Soc
Convalescent Antibodies after Omicron Infection Although considerable data show cross-
reactivity among antibodies generated by infection with the various SARS-CoV-2 variants of …
reactivity among antibodies generated by infection with the various SARS-CoV-2 variants of …